19/11/2025
🖐️ Elveflow helps: Accelerating Sepsis Detection
🩸 Sepsis affects nearly 50 million people every year and causes 13 million deaths, with survival rates dropping by 8% for every hour of delayed treatment. Rapid identification of pathogens and their antibiotic susceptibility is therefore vital.
🧫 In this study from Prof. Wouter van der Wijngaart’s team at KTH Royal Institute of Technology 🇸🇪, led by PhD researcher Henar Marino Miguélez, the researchers developed a culture-free method to isolate and identify bacteria from whole blood within 2 hours.
🧠 Their approach combines smart centrifugation, microfluidic trapping, and deep learning-based microscopy analysis, enabling the detection of E. coli, K. pneumoniae, and E. faecalis at clinically relevant concentrations as low as 7–32 CFU/mL.
💧 Precise flow control during the microfluidic trapping stage was achieved using Elveflow OB1 pressure controllers, ensuring stable and reproducible conditions for real-time bacterial capture and imaging.
⚙️ This study represents a major step toward rapid, culture-free sepsis diagnostics, bringing us closer to real-time pathogen detection in clinical environments.
📄 Read the full article:
[Culture-free detection of bacteria from blood for rapid sepsis diagnosis](https://go.nature.com/4oAQn9G)
🔬 Discover the most accurate pressure controller for microfluidics:
[OB1 by Elveflow](https://bit.ly/47tk85c)